Iain Shield (Associate Director – Market Access, Mtech Access) discusses updates to prescribing information (Clause 12) in the ABPI Code of Practice and the considerations for digital materials
Read More
Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of ‘willingness to pay’ (WTP). Read on to explore 4 factors that impact WTP and compare 5 methodologies for price testing with payers.
A symposium for UK market access leaders The healthcare landscape is continuously evolving, and the need for effective collaboration between the NHS and industry partners has never been more critical....
Read More
Louise Maddison joined Mtech Access as a Senior Consultant in our Market Access Team, earlier this year. Here, she talks about her career journey and her experiences since joining Mtech Access.
Discover how data visualisation dashboards can aid field teams in market access discussions with customers Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with...
Read More
Calum Jones (Associate Director – Health Economics) shares his experience speaking at the 2024 HTAi Conference. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health Technology Assessment (HTA): From Trials to Economic Evaluations’.
Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US and highlight important considerations for companies seeking to infiltrate this key market.
We delve into ICER’s influence on drug pricing and access in the US. We also explore the importance of maximising engagement with ICER for favourable pricing and access outcomes.
We're thrilled to announce that Mtech Access will be exhibiting at the ISPOR conference May 5–8 in Atlanta, Georgia, USA! As regular attendees of ISPOR Europe, we're excited to be...
Read More
What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health...
Read More
